logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On January 9th, HSBC Holdings (00005) spent approximately HK$35.61 million to repurchase 468,800 shares in Hong Kong.

date
17:26 10/01/2025
avatar
GMT Eight
HSBC Holdings (00005) announced that it will repurchase approximately 10,780,500 in the UK on January 9, 2025.
HSBC Holdings (00005) announced that on January 9, 2025, it will spend approximately 10.78 million to repurchase around 135.25 million shares in the UK, and approximately HK$35.6123 million to repurchase about 46.88 million shares in Hong Kong.
Related Articles
US Stock Market Move | The phase III trial of melanoma drug did not reach the primary endpoint, causing Regeneron Pharmaceuticals, Inc. (RENG.US) to drop more than 10% in early trading.
HK Stock
AIM VACCINE (06660): Wen Jie Resigns as Independent Non-executive Director.
HK Stock
CH BIOTECH SER (08037) intends to sell the entire equity of Standard Pathology Laboratory and Jockey Health for a total of HK$3.5 million
US Stock Market Move | The phase III trial of melanoma drug did not reach the primary endpoint, causing Regeneron Pharmaceuticals, Inc. (RENG.US) to drop more than 10% in early trading.
AIM VACCINE (06660): Wen Jie Resigns as Independent Non-executive Director.
HK Stock
CH BIOTECH SER (08037) intends to sell the entire equity of Standard Pathology Laboratory and Jockey Health for a total of HK$3.5 million
HK Stock
RECOMMEND
Hong Kong AI Stocks Surge on Anthropic Fundraising and Benchmark Results
Hong Kong AI Stocks Surge on Anthropic Fundraising and Benchmark Results
icon
15/05/2026
U.S. and China Trade Shifts Buffer Global Oil Shock
U.S. and China Trade Shifts Buffer Global Oil Shock
icon
15/05/2026
Alibaba Highlights AI Returns While Tencent Ramps Up Spending
Alibaba Highlights AI Returns While Tencent Ramps Up Spending
icon
15/05/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.